Although there was no significant association between ERBB2 expression and the stage and recurrence of GC (Figures S2), ERBB2 was identified as a crucial regulator in the immune microenvironment and for the metabolic remodelling of GC (Figures 2A, B). This evidence concerns the gene ERBB2 and gastric cancer.